Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:489493.
doi: 10.1155/2014/489493. Epub 2014 Nov 4.

QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis

Xian-Bin Li  1 , Yi-Lang Tang  2 , Wei Zheng  3 , Chuan-Yue Wang  1 , Jose de Leon  4
Affiliations

QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis

Xian-Bin Li et al. Case Rep Psychiatry. 2014.

Abstract

Intramuscular (IM) ziprasidone has been associated with QTc interval prolongations in patients with preexisting risk factors. A 23-year-old male Chinese schizophrenia patient experienced an increase of QTc interval of 83 milliseconds (ms) after receiving 20 mg IM ziprasidone (baseline and increased QT/QTc were, respectively, 384/418 and 450/501). This was rated as a probable adverse drug reaction (ADR) by the Liverpool ADR causality assessment tool. A systematic review including all types of trials reporting the effect of IM ziprasidone on the QTc interval prolongation identified 19 trials with a total of 1428 patients. Mean QTc change from baseline to end of each study was -3.7 to 12.8 ms after IM ziprasidone. Four randomized trials (3 of 4 published in Chinese) were used to calculate a meta-analysis of QTc interval prolongation which showed no significant differences between IM ziprasidone and IM haloperidol groups (risk ratio 0.49 to 4.31, 95% confidence interval 0.09 to 19.68, P = 0.06 to 0.41). However, our review included two cases of patients who experienced symptoms probably related to QTc prolongation after IM ziprasidone. Thus, careful screening and close monitoring, including baseline ECG, should be considered in patients receiving IM ziprasidone for the first time.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
Meta-analysis comparing QTc in patients with intramuscular ziprasidone versus haloperidol.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Brook S., Walden J., Benattia I., Siu C. O., Romano S. J. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology. 2005;178(4):514–523. doi: 10.1007/s00213-004-2082-5. - DOI - PubMed
    1. Witsil J. C., Zell-Kanter M., Mycyk M. B. Single-dose ziprasidone associated with QT interval prolongation. The American Journal of Emergency Medicine. 2012;30(5):837.e1–837.e2. doi: 10.1016/j.ajem.2011.03.019. - DOI - PubMed
    1. Glassman A. H., Bigger J. T. J. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. The American Journal of Psychiatry. 2001;158(11):1774–1782. doi: 10.1176/appi.ajp.158.11.1774. - DOI - PubMed
    1. Tambyraja R., Strawn J. R. Third degree heart block following intramuscular ziprasidone. Schizophrenia Research. 2011;125(2-3):302–303. doi: 10.1016/j.schres.2010.07.015. - DOI - PubMed
    1. Keck P. E., Jr., Versiani M., Potkin S., West S. A., Giller E., Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. The American Journal of Psychiatry. 2003;160(4):741–748. doi: 10.1176/appi.ajp.160.4.741. - DOI - PubMed

LinkOut - more resources